Literature DB >> 14659524

Peripheral group II metabotropic glutamate receptors mediate endogenous anti-allodynia in inflammation.

Dongni Yang1, Robert W Gereau.   

Abstract

We previously demonstrated that activation of peripheral group II mGluRs inhibits PGE2-induced thermal hyperalgesia. In the present study we examined the role of peripheral group II mGluRs in inflammation-induced mechanical allodynia in CD1 mice. Subcutaneous injection of group II mGluR agonists or antagonists into the plantar surface of the mouse hind paw did not alter mechanical thresholds, suggesting that peripheral group II mGluRs did not modulate basal mechanical sensation. We then used either PGE2 or carrageenan to induce mechanical allodynia and investigated the effects of activating or inhibiting peripheral group II mGluRs. PGE2-injected mice showed an 87+/-1% decrease of mechanical thresholds 75 min after the injection, whereas mice injected with group II mGluR agonists had no increase in sensitivity compared to vehicle-injected mice. In the carrageenan-induced inflammation model, 3 h after carrageenan injection the mechanical thresholds of mice injected with group II mGluR agonist APDC fully recovered to baseline levels while vehicle-injected mice showed only 43+/-8% recovery. The application of group II mGluR antagonist (LY341495) alone delayed the recovery of PGE2- and carrageenan-induced mechanical allodynia. Three hours after injection of carrageenan, LY341495-injected mice showed little or no recovery with mechanical thresholds 8+/-1% of pre-carrageenan baselines, compared to 57+/-8% of pre-carrageenan baselines in vehicle-injected mice at the same time point. Our results suggest that activation of peripheral group II mGluRs reduces inflammation-induced mechanical allodynia and that peripheral group II mGluRs may mediate endogenous anti-allodynia effects, which speed recovery from inflammation-induced hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14659524     DOI: 10.1016/j.pain.2003.08.011

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  31 in total

1.  Group II metabotropic glutamate receptor activation attenuates peripheral sensitization in inflammatory states.

Authors:  J Du; S Zhou; S M Carlton
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

2.  Pharmacological attenuation of chronic alcoholic pancreatitis induced hypersensitivity in rats.

Authors:  Sabrina L McIlwrath; Karin N Westlund
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 3.  Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.

Authors:  Joseph H Neale; Rafal T Olszewski; Daiying Zuo; Karolina J Janczura; Caterina P Profaci; Kaleen M Lavin; John C Madore; Tomasz Bzdega
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

4.  2020 Foresight: Envisioning Therapeutic Innovations for Pain.

Authors:  May Hamza; Raymond A Dionne
Journal:  Drug Discov Today Ther Strateg       Date:  2009

Review 5.  Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation.

Authors:  Michael C Montana; Robert W Gereau
Journal:  Curr Pharm Biotechnol       Date:  2011-10       Impact factor: 2.837

6.  Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits chronic inflammatory pain behaviors in mice.

Authors:  Feng Tao; Qingning Su; Roger A Johns
Journal:  Mol Ther       Date:  2008-09-09       Impact factor: 11.454

7.  Pharmacokinetics and pharmacodynamics of the glutamate carboxypeptidase II inhibitor 2-MPPA show prolonged alleviation of neuropathic pain through an indirect mechanism.

Authors:  James J Vornov; Krystyna M Wozniak; Ying Wu; Camilo Rojas; Rana Rais; Barbara S Slusher
Journal:  J Pharmacol Exp Ther       Date:  2013-06-17       Impact factor: 4.030

Review 8.  [Symptoms and pathophysiological mechanisms of neuropathic pain syndromes].

Authors:  S Lanz; C Maihöfner
Journal:  Nervenarzt       Date:  2009-04       Impact factor: 1.214

Review 9.  Acetyl-L-carnitine in neuropathic pain: experimental data.

Authors:  Santina Chiechio; Agata Copani; Robert W Gereau; Ferdinando Nicoletti
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  The effects of tail biopsy for genotyping on behavioral responses to nociceptive stimuli.

Authors:  Maria Elena P Morales; Robert W Gereau
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.